GE HealthCare Technologies Inc. 8-K

What Happened

• GE HealthCare Technologies Inc. announced on Feb 26, 2026 that it entered into a new 364-Day Revolving Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent and participating lenders. The facility provides a $0.5 billion senior unsecured revolving credit line and replaces the prior 2025 364-Day Revolving Credit Agreement, which was terminated without penalty on Feb 26, 2026. The new facility matures on Feb 25, 2027.

Key Details

• Facility size: $0.5 billion (364-day senior unsecured revolving credit facility).
• Effective/filing dates: Credit agreement dated Feb 26, 2026; 8-K filed Feb 27, 2026.
• Maturity: Feb 25, 2027.
• Interest: For USD borrowings, at Company’s option — alternate base rate, daily simple SOFR, or adjusted Term SOFR (1-, 3-, or 6-month), plus an applicable margin; EUR borrowings priced at EURIBOR; GBP borrowings priced at daily simple SONIA, each plus a margin tied to the company’s senior unsecured long-term debt ratings.
• Covenants and defaults: Includes customary covenants limiting liens, certain fundamental changes, a maximum leverage ratio, and subsidiary indebtedness, and customary events of default (e.g., payment failures, covenant breaches, insolvency, change of control).
• Exhibit: The full credit agreement is filed as Exhibit 10.1 to the 8-K.

Why It Matters

• This transaction secures near-term liquidity and short-term borrowing capacity for GE HealthCare through Feb 2027, replacing the prior one-year facility on similar terms.
• Borrowing costs under the facility will vary with market rates (SOFR/EURIBOR/SONIA) and the company’s credit ratings, so interest expense could change if ratings or market rates move.
• The covenants may limit certain corporate actions (e.g., additional secured debt or large transactions), which is relevant for investors monitoring balance sheet flexibility and refinancing risk ahead of the facility’s 2027 maturity.